Monday, March 27, 2017 2:07:28 PM
The aromatic PCU ChronoFlex AR (CF, AdvanSource Biomaterials, Wilmington, MA, USA) was processed according to the manufacturer's instructions
"Polycarbonate urethanes (PCUs) have been used in implantable medical devices because of their superior biocompatibility, attractive mechanical properties, and improved oxidative biostability [1–5]. However, thrombus formation may still occur when artificial organs and biomedical devices made of PCU are in contact with blood for extended periods of time [6–8].
Currently this is managed by anti-platelet therapy, however, this presents a risk of bleeding[8]. Therefore, there remains a pressing need for non-thrombogenic surface coatings that can reduce this reliance on pharmacological intervention."
http://www.mdpi.com/search?q=CHRONOFLEX
Recent NORD News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/23/2024 05:54:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 05:54:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 09:30:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2024 09:09:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:51:03 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 06/05/2024 08:49:01 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 06/05/2024 05:24:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:52:27 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/04/2024 08:51:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 06:11:42 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 05/28/2024 08:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 02:19:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2024 07:02:29 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/06/2023 08:46:07 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/27/2023 10:16:50 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM